Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer Genetics and Therapeutic Opportunities in Urologic Practice.
Adashek JJ, Leonard A, Roszik J, Menta AK, Genovese G, Subbiah V, Msaouel P. Adashek JJ, et al. Among authors: subbiah v. Cancers (Basel). 2020 Mar 18;12(3):710. doi: 10.3390/cancers12030710. Cancers (Basel). 2020. PMID: 32197306 Free PMC article. Review.
Towards precision oncology in RET-aberrant cancers.
Subbiah V, Roszik J. Subbiah V, et al. Cell Cycle. 2017 May 3;16(9):813-814. doi: 10.1080/15384101.2017.1302235. Epub 2017 Mar 20. Cell Cycle. 2017. PMID: 28318386 Free PMC article. No abstract available.
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.
Subbiah V, Meyer C, Zinner R, Meric-Bernstam F, Zahurak ML, O'Connor A, Roszik J, Shaw K, Ludwig JA, Kurzrock R, Azad NA. Subbiah V, et al. Clin Cancer Res. 2017 Aug 1;23(15):4027-4034. doi: 10.1158/1078-0432.CCR-17-0272. Epub 2017 Apr 4. Clin Cancer Res. 2017. PMID: 28377484 Free PMC article. Clinical Trial.
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
Dembla V, Groisberg R, Hess K, Fu S, Wheler J, Hong DS, Janku F, Zinner R, Piha-Paul SA, Ravi V, Benjamin RS, Patel S, Somaiah N, Herzog CE, Karp DD, Roszik J, Meric-Bernstam F, Subbiah V. Dembla V, et al. Among authors: subbiah v. Sci Rep. 2017 Nov 21;7(1):15963. doi: 10.1038/s41598-017-13114-8. Sci Rep. 2017. PMID: 29162825 Free PMC article.
Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers.
Groisberg R, Hong DS, Roszik J, Janku F, Tsimberidou AM, Javle M, Meric-Bernstam F, Subbiah V. Groisberg R, et al. Among authors: subbiah v. Mol Cancer Ther. 2018 Jul;17(7):1595-1601. doi: 10.1158/1535-7163.MCT-17-1107. Epub 2018 Apr 13. Mol Cancer Ther. 2018. PMID: 29654067 Free PMC article.
Mining Public Databases for Precision Oncology.
Roszik J, Subbiah V. Roszik J, et al. Among authors: subbiah v. Trends Cancer. 2018 Jul;4(7):463-465. doi: 10.1016/j.trecan.2018.04.008. Epub 2018 May 22. Trends Cancer. 2018. PMID: 29937043 Review.
High-Throughput Architecture for Discovering Combination Cancer Therapeutics.
Gianni M, Qin Y, Wenes G, Bandstra B, Conley AP, Subbiah V, Leibowitz-Amit R, Ekmekcioglu S, Grimm EA, Roszik J. Gianni M, et al. Among authors: subbiah v. JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.17.00054. JCO Clin Cancer Inform. 2018. PMID: 30652536 Free PMC article.
578 results